These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11368382)

  • 81. Selecting unrelated donor grafts to prevent leukaemia relapse.
    Szabolcs P
    Lancet Oncol; 2010 Jul; 11(7):608-9. PubMed ID: 20558105
    [No Abstract]   [Full Text] [Related]  

  • 82. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
    Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A
    Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient.
    Basara N; Blau WI; Kiehl MG; Römer E; Rudolphi M; Bischoff M; Kirsten D; Sanchez H; Günzelmann S; Fauser AA
    Transplant Proc; 1998 Dec; 30(8):4087-9. PubMed ID: 9865306
    [No Abstract]   [Full Text] [Related]  

  • 84. Immune recovery after bone marrow and peripheral blood stem cells transplantation.
    Marin GH; Mendez MC; Menna ME; Malacalza J; Bergna MI; Klein G; Italiano C; Perez M; Gil MA; Gardenal L; Mansilla E; Orlando S; Saba S; Cánepa C; Piccinelli G
    Transplant Proc; 1999 Sep; 31(6):2582-4. PubMed ID: 10500728
    [No Abstract]   [Full Text] [Related]  

  • 85. Marrow vs peripheral blood: impact on transplant outcome.
    Forman SJ
    Leukemia; 2001 Apr; 15(4):686-7. PubMed ID: 11368382
    [No Abstract]   [Full Text] [Related]  

  • 86. [Transplantation of hematopoietic stem cells].
    Hertenstein B; Novotny J; Ebell W; Ganser A
    Internist (Berl); 1996 Mar; 37(3):295-303. PubMed ID: 8919947
    [No Abstract]   [Full Text] [Related]  

  • 87. [Graft-versus-leukemia reactions].
    Ju X; Wang J
    Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):443-5. PubMed ID: 11721426
    [No Abstract]   [Full Text] [Related]  

  • 88. [Current status and issues in hematopoietic stem cell transplantation].
    Harada M
    Fukuoka Igaku Zasshi; 2007 Feb; 98(2):35-47. PubMed ID: 17396570
    [No Abstract]   [Full Text] [Related]  

  • 89. [Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].
    Nguyen S; Chalandon Y; Lemarie C; Simon S; Masson D; Dhedin N; Suarez F; Renaud B; Charbonnier A; Yafour N; François S; Duléry R; Blaise D; Yakoub-Agha I; Rubio MT
    Bull Cancer; 2016 Nov; 103(11S):S229-S242. PubMed ID: 27842860
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Value of hematopoietic stem cell transplantation in treatment of leukemia].
    Runde V; Schaefer UW
    Internist (Berl); 1996 Oct; 37(10):1030-9. PubMed ID: 9019447
    [No Abstract]   [Full Text] [Related]  

  • 91. The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer.
    Appelbaum FR
    CA Cancer J Clin; 1996; 46(3):142-64. PubMed ID: 8646545
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Cellular mechanism for granulocyte-colony stimulating factor in the prevention of graft-versus-host disease in combined bone marrow and peripheral blood transplantation for hematological malignancies: the composition in collection.
    Zhang C; Zhang X; Chen XH
    Transfus Apher Sci; 2013 Feb; 48(1):3-9. PubMed ID: 23279971
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Perspectives in marrow graft T-cell depletion in allogeneic matched related bone marrow transplantation.
    Tiberghien P; Hervé P
    Transfus Sci; 1992; 13(4):443-54. PubMed ID: 10147740
    [No Abstract]   [Full Text] [Related]  

  • 94. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].
    Michallet M; Dhedin N; Michallet AS
    Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL.
    Nash RA; Storb R
    Curr Opin Immunol; 1996 Oct; 8(5):674-80. PubMed ID: 8902393
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Allogeneic peripheral blood stem cell transplantation].
    Harada M
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1877-85. PubMed ID: 8978790
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Allogeneic peripheral blood stem cell transplantation (allo PBSCT) compared with allogeneic bone marrow transplantation (allo BMT)].
    Tanaka J
    Rinsho Ketsueki; 2002 Jun; 43(6):442-6. PubMed ID: 12134697
    [No Abstract]   [Full Text] [Related]  

  • 98. Peripheral blood stem cell versus bone marrow transplantation: A perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Byrne M; Savani BN; Mohty M; Nagler A
    Exp Hematol; 2016 Jul; 44(7):567-73. PubMed ID: 27106798
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Granulocyte-mobilized bone marrow.
    Arcese W; De Angelis G; Cerretti R
    Curr Opin Hematol; 2012 Nov; 19(6):448-53. PubMed ID: 22954729
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.